MedPath

Role of drug ( dexmedetomidine) in controlling the intubation response.

Phase 2
Conditions
Health Condition 1: null- controlled diabetics, normal patients, male and female , 18-60 years of age.Health Condition 2: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2018/07/014837
Lead Sponsor
IZAMS INSTITUTE OF MEDICAL SCIENCES
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)ASA I ,II

2)Age group 18- 60 yrs

3)male/female

4)patients with normal airway parameters.

5)Patients posted for elective surgeries under general anaesthesia with endotracheal intubation

Exclusion Criteria

1)ASA III,IV,V,VI.

2)patients with anticipated difficult intubation or difficult mask ventilation.

3)Patients with uncontrolled hypertension, cardiac disorders where haeodynamic responses to intubation may be not be tolerated .

4)Patients with poor pulmonary reserve where early desaturation is expected.

5)patients with active secreting adrenal tumors.

6)patients with large thyroid mass or other neck masses precipitating difficult airway.

7)Patients with BMI > 30 kg/m2.

8)Pediatric age group

9)pregnant females

10)C-spine fracture or other cervical disorders with restricted neck movement or unstable cervical spine

11)faciomaxillary injury or anomalies

12)abnormalities of airway like burn contractures and cleft lip/palate,TMJ ankylosis.

13)Unwillingness to give consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath